The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000714381p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
8/05/2026
Date registered
Help: Date registered
16/06/2026
Date last updated
Help: Date last updated
16/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
16/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Evaluating the effect of self-mobilisation for individuals with lateral elbow tendinopathy
Scientific title
Evaluating the effect of self-mobilisation on pain in individuals with lateral elbow tendinopathy: A single case experimental design
Additional trial identifiers [1] 317228 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Lateral elbow tendinopathy 341832 0
Condition category
Condition code
Musculoskeletal 337903 337903 0 0
Other muscular and skeletal disorders

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Intervention: Self mobilisation exercise for lateral elbow tendinopathy

Following enrolment into the study, participants will be randomly allocated using a computer-generated sequence to 1 of 3 baseline periods: 7 days, 10 days or 13 days.
Participants will perform self mobilisation of their elbow as a home exercise following the baseline period - starting Day 8, 11 or 14.

Participants will attend a face-to-face instruction session (~30 minutes) with a registered physiotherapist with postgraduate qualifications where they will be provided with verbal and written instruction on how to perform the self mobilisation exercise – either a lateral glide of the humeroulnar joint or posterior-anterior glide of the radius with pain-free gripping.

To perform the self-lateral glide of the humeroulnar joint with pain-free gripping, participants will stand next to a wall with the upper arm stabilised against the wall and elbow flexed to 90°. Participants will place their other hand on the medial aspect of the forearm just below the elbow joint and apply a glide laterally. Participants will grip until their first onset of pain while maintaining the glide (~3-5 second hold). The glide is then released.

To perform the self-posterior-anterior glide of the radius with pain-free gripping, participants will be positioned in standing or sitting with their elbow fully extended. Participants will place their index and middle finger on the radial head and apply a posterior-anterior glide. Participants will grip until their first onset of pain while maintaining the glide (~3-5 second hold). The glide is then released.

Glide selection will be individualised based on which technique produces the greatest immediate improvement in pain-free grip strength during the assessment; if neither technique produces greater improvement, the lateral glide will be used as the default. Participants must demonstrate correct technique before commencing the home program of self mobilisation exercises.

Participants will complete the home program of self mobilisation exercises independently and unsupervised. Participants will perform 1 set of 10 repetitions of the self mobilisation exercise daily for 2 weeks. Participants will record their exercise adherence on a paper diary.
Intervention code [1] 334004 0
Treatment: Other
Intervention code [2] 334005 0
Rehabilitation
Description of the comparator or control
There is no control group. In a single-case experimental design, each participant serves as their own control. The intervention phase will be compared with a no-treatment baseline period. Participants will be randomly allocated using a computer-generated sequence to 1 of 3 baseline lengths - 7, 10 or 13 days.
Control group
Active

Outcomes
Primary outcome [1] 345358 0
Pain-free grip strength (PFGS) of the affected arm
Timepoint [1] 345358 0
There is no primary timepoints in a single-case experimental design trial. Participants will complete PFGS daily during all phases of the trial, including the baseline monitoring period (7-13 days), intervention phase, and at 2-week follow-up.
Secondary outcome [1] 461384 0
Pain intensity during and after gripping at 25% perceived maximum grip strength on the affected arm.
Timepoint [1] 461384 0
Pain intensity during and after gripping at 25% perceived maximum grip strength will be assessed daily during all phases of the trial, including the baseline monitoring period (7-13 days), intervention phase, and at 2-week follow-up.
Secondary outcome [2] 461385 0
Pain intensity during and after gripping at 50% perceived maximum grip strength on the affected arm.
Timepoint [2] 461385 0
Pain intensity during and after gripping at 50% perceived maximum grip strength will be assessed daily during all phases of the trial, including the baseline monitoring period (7-13 days), intervention phase, and at 2-week follow-up.
Secondary outcome [3] 462794 0
Pain intensity during and after gripping at 75% perceived maximum grip strength on the affected arm.
Timepoint [3] 462794 0
Pain intensity during and after gripping at 75% perceived maximum grip strength will be assessed daily during all phases of the trial, including the baseline monitoring period (7-13 days), intervention phase, and at 2-week follow-up.

Eligibility
Key inclusion criteria
Inclusion criteria:
1) participants aged 18 to 70 years
2) unilateral lateral elbow tendinopathy of at least 6 weeks’ duration
3) average pain severity during the past week greater than or equal to 3 on a 11-point numerical rating scale
4) pain over the lateral epicondyle or common extensor tendon that is aggravated by at least 2 of: palpation, gripping, resisted third finger or wrist extension, or stretching of forearm extensor muscles
5) reduced pain-free grip strength
Minimum age
18 Years
Maximum age
70 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Exclusion criteria:
1) other sources of elbow pain (e.g., exacerbation of elbow pain with neck movements or manual palpation, pain localized over the radiohumeral joint, abnormal findings on neurological examination)
2) concomitant musculoskeletal pain conditions reported by participants to be their predominant complaint
3) major neurological, inflammatory or systemic conditions
4) a history of elbow dislocation, fracture or tendon rupture in the last year
5) any injections within the previous 6 months
6) any treatment by a healthcare practitioner within the preceding 3 months
7) Participants who don’t have sufficient English language proficiency to understand the study procedures

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 321805 0
University
Name [1] 321805 0
The University of Queensland
Country [1] 321805 0
Australia
Primary sponsor type
University
Name
The University of Queensland
Address
Country
Australia
Secondary sponsor category [1] 324656 0
None
Name [1] 324656 0
Address [1] 324656 0
Country [1] 324656 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320350 0
The University of Queensland Human Research Ethics Committee A
Ethics committee address [1] 320350 0
Ethics committee country [1] 320350 0
Australia
Date submitted for ethics approval [1] 320350 0
25/03/2026
Approval date [1] 320350 0
Ethics approval number [1] 320350 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150182 0
Dr Viana Vuvan
Address 150182 0
School of Health and Rehabilitation Sciences, The University of Queensland, St Lucia, QLD 4072
Country 150182 0
Australia
Phone 150182 0
+61 7 3365 2209
Fax 150182 0
Email 150182 0
Contact person for public queries
Name 150183 0
Viana Vuvan
Address 150183 0
School of Health and Rehabilitation Sciences, The University of Queensland, St Lucia, QLD 4072
Country 150183 0
Australia
Phone 150183 0
+61 7 3365 2209
Fax 150183 0
Email 150183 0
Contact person for scientific queries
Name 150184 0
Viana Vuvan
Address 150184 0
School of Health and Rehabilitation Sciences, The University of Queensland, St Lucia, QLD 4072
Country 150184 0
Australia
Phone 150184 0
+61 7 3365 2209
Fax 150184 0
Email 150184 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
What individual participant data might be shared?
• De-identified individual participant data:
• All outcomes data
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
A finite period of: 15 years
Where can requests to access individual participant data be made, or data be obtained directly?
• Data can be obtained by contacting the corresponding author: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.